Paul V. Imperatore’s practice focuses on domestic and cross-border public and private mergers and acquisitions, venture capital-style minority investments, and corporate governance matters.

Paul has particular experience in transactions involving private equity firms and other financial sponsors.

Paul joined the firm in 2013 and became a partner in 2022.

Read More

Notable Experience

  • Warburg Pincus in numerous transactions, including:

    • its $2.16 billion sale of Sundyne to Honeywell International;
    • its acquisition, together with Vista Equity Partners, of Redwood Software;
    • its equity investment in CData Software;
    • its investment in Internet Brands;
    • its acquisition of Sweeping Corp of America from Soundcore Capital Partners;
    • its acquisition of FlexXray; and
    • its acquisition of Sotera Health (formerly Sterigenics) and the subsequent $1.1 billion initial public offering of Sotera Health.

  • Blackstone in various transactions, including:

    • Blackstone Life Sciences and Novo in their respective investments in Series B preferred stock of Anthos Therapeutics, and the subsequent $3.1 billion sale of Anthos Therapeutics to Novartis AG;
    • Blackstone, as selling shareholder, in the initial public offering of Hamilton Insurance Group, and the repurchase by Hamilton Insurance Group, Ltd. of the entirety of Blackstone’s minority stake in Hamilton; and
    • Blackstone Life Sciences in its additional $75 million investment in GRIN Therapeutics.

  • Advent International and Warburg Pincus in their $4.25 billion acquisition of BioPharma Solutions.

  • Summit Health-CityMD, a Warburg Pincus portfolio company, in its $8.9 billion sale to VillageMD.

  • Summit Health-CityMD in various matters, including:

    • CityMD’s combination with Summit Medical Group and the acquisition of Summit Medical Group’s affiliated management company, Zoonie; 
    • Summit Health’s combinations with Westchester Medical Group and New Jersey Urologists.

  • Viking Global in various matters, including:

    • its acquisition of a majority interest in Birchbox;
    • its minority investment in Credit Karma;
    • its PIPE investment in Api Group and subsequent sale of equity in APi Group; and
    • its PIPE investment in InhibRx.

  • OCI in its $3.6 billion strategic sale of its indirect interests in its large-scale U.S. greenfield nitrogen fertilizer facility Iowa Fertilizer Company to Koch.

  • Duravant, a portfolio company of Warburg Pincus and Carlyle, in its acquisition of Pattyn Group.

  • Global Healthcare Exchange in its acquisition of Prodigo.

  • Gabe’s, a Warburg Pincus portfolio company, in its acquisition of Old Time Pottery.

  • Sony Interactive Entertainment in its acquisition of Bungie.

  • International Seaways in its stock-for-stock merger with Diamond S Shipping.

  • Walgreens Boots Alliance in various matters, including in its $6.5 billion strategic transaction with AmerisourceBergen Corporation.

  • América Móvil in its $6.9 billion sale of its TracFone Wireless subsidiary to Verizon Communications Inc.

  • América Móvil in its $333 million acquisition of Telefónica’s operations in Guatemala and terminated $315 million acquisition of Telefónica’s operations in El Salvador.

  • Saint-Gobain in its $1.4 billion acquisition of Continental Building Products.

  • TPG Capital in its investment in Uber.

  • Roquette Frères in its acquisition of Sethness Products Company.

See More

Publications

Paul published two notes in the Georgetown Law Journal.

The Change Healthcare Decision and Implications for Private Equity Sponsors

Events